BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8740509)

  • 1. Quantification of osteopontin in human plasma with an ELISA: basal levels in pre- and postmenopausal women.
    Bautista DS; Saad Z; Chambers AF; Tonkin KS; O'Malley FP; Singhal H; Tokmakejian S; Bramwell V; Harris JF
    Clin Biochem; 1996 Jun; 29(3):231-9. PubMed ID: 8740509
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.
    Singhal H; Bautista DS; Tonkin KS; O'Malley FP; Tuck AB; Chambers AF; Harris JF
    Clin Cancer Res; 1997 Apr; 3(4):605-11. PubMed ID: 9815727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma.
    Standal T; Hjorth-Hansen H; Rasmussen T; Dahl IM; Lenhoff S; Brenne AT; Seidel C; Baykov V; Waage A; Børset M; Sundan A; Hjertner O
    Haematologica; 2004 Feb; 89(2):174-82. PubMed ID: 15003892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system.
    Vordermark D; Said HM; Katzer A; Kuhnt T; Hänsgen G; Dunst J; Flentje M; Bache M
    BMC Cancer; 2006 Aug; 6():207. PubMed ID: 16911785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas.
    Le QT; Sutphin PD; Raychaudhuri S; Yu SC; Terris DJ; Lin HS; Lum B; Pinto HA; Koong AC; Giaccia AJ
    Clin Cancer Res; 2003 Jan; 9(1):59-67. PubMed ID: 12538452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced production of osteopontin in multiple myeloma: clinical and pathogenic implications.
    Saeki Y; Mima T; Ishii T; Ogata A; Kobayashi H; Ohshima S; Ishida T; Tabunoki Y; Kitayama H; Mizuki M; Katada Y; Asaoku H; Kitano M; Nishimoto N; Yoshizaki K; Maeda M; Kon S; Kinoshita N; Uede T; Kawase I
    Br J Haematol; 2003 Oct; 123(2):263-70. PubMed ID: 14531907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated plasma osteopontin levels in patients with hepatocellular carcinoma.
    Kim J; Ki SS; Lee SD; Han CJ; Kim YC; Park SH; Cho SY; Hong YJ; Park HY; Lee M; Jung HH; Lee KH; Jeong SH
    Am J Gastroenterol; 2006 Sep; 101(9):2051-9. PubMed ID: 16848813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies to different peptides in osteopontin reveal complexities in the various secreted forms.
    Kon S; Maeda M; Segawa T; Hagiwara Y; Horikoshi Y; Chikuma S; Tanaka K; Rashid MM; Inobe M; Chambers AF; Uede T
    J Cell Biochem; 2000 Apr; 77(3):487-98. PubMed ID: 10760956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma osteopontin: associations with survival and metastasis to bone in men with hormone-refractory prostate carcinoma.
    Hotte SJ; Winquist EW; Stitt L; Wilson SM; Chambers AF
    Cancer; 2002 Aug; 95(3):506-12. PubMed ID: 12209742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New dual monoclonal ELISA for measuring plasma osteopontin as a biomarker associated with survival in prostate cancer: clinical validation and comparison of multiple ELISAs.
    Anborgh PH; Wilson SM; Tuck AB; Winquist E; Schmidt N; Hart R; Kon S; Maeda M; Uede T; Stitt LW; Chambers AF
    Clin Chem; 2009 May; 55(5):895-903. PubMed ID: 19325010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The value of osteopontin in the assessment of bone mineral density status in postmenopausal women.
    Fodor D; Bondor C; Albu A; Simon SP; Craciun A; Muntean L
    J Investig Med; 2013 Jan; 61(1):15-21. PubMed ID: 23117696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of fragment-specific osteopontin antibodies and ELISA for quantification in human metastatic breast cancer.
    Plumer A; Duan H; Subramaniam S; Lucas FL; Miesfeldt S; Ng AK; Liaw L
    BMC Cancer; 2008 Jan; 8():38. PubMed ID: 18237408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High plasma concentrations of osteopontin in patients with interstitial pneumonia.
    Kadota J; Mizunoe S; Mito K; Mukae H; Yoshioka S; Kawakami K; Koguchi Y; Fukushima K; Kon S; Kohno S; Saito A; Uede T; Nasu M
    Respir Med; 2005 Jan; 99(1):111-7. PubMed ID: 15672859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight variants of osteopontin generated by serine proteinases in urine of patients with kidney stones.
    Bautista DS; Denstedt J; Chambers AF; Harris JF
    J Cell Biochem; 1996 Jun; 61(3):402-9. PubMed ID: 8761944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoprotegerin and osteopontin serum values in postmenopausal advanced breast cancer patients treated with anastrozole.
    Martinetti A; Bajetta E; Ferrari L; Zilembo N; Seregni E; Del Vecchio M; Longarini R; La Torre I; Toffolatti L; Paleari D; Bombardieri E
    Endocr Relat Cancer; 2004 Dec; 11(4):771-9. PubMed ID: 15613451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative plasma osteopontin level as a biomarker complementary to carbohydrate antigen 125 in predicting ovarian cancer.
    Nakae M; Iwamoto I; Fujino T; Maehata Y; Togami S; Yoshinaga M; Douchi T
    J Obstet Gynaecol Res; 2006 Jun; 32(3):309-14. PubMed ID: 16764622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin as an adjunct to CA125 in detecting recurrent ovarian cancer.
    Schorge JO; Drake RD; Lee H; Skates SJ; Rajanbabu R; Miller DS; Kim JH; Cramer DW; Berkowitz RS; Mok SC
    Clin Cancer Res; 2004 May; 10(10):3474-8. PubMed ID: 15161704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced local production of osteopontin in rheumatoid joints.
    Ohshima S; Yamaguchi N; Nishioka K; Mima T; Ishii T; Umeshita-Sasai M; Kobayashi H; Shimizu M; Katada Y; Wakitani S; Murata N; Nomura S; Matsuno H; Katayama R; Kon S; Inobe M; Uede T; Kawase I; Saeki Y
    J Rheumatol; 2002 Oct; 29(10):2061-7. PubMed ID: 12375312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microarray analysis of human milk cells: persistent high expression of osteopontin during the lactation period.
    Nagatomo T; Ohga S; Takada H; Nomura A; Hikino S; Imura M; Ohshima K; Hara T
    Clin Exp Immunol; 2004 Oct; 138(1):47-53. PubMed ID: 15373904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct roles of osteopontin fragments in the development of the pulmonary involvement in sarcoidosis.
    Maeda K; Takahashi K; Takahashi F; Tamura N; Maeda M; Kon S; Uede T; Fukuchi Y
    Lung; 2001; 179(5):279-91. PubMed ID: 11976896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.